+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amniotic Membrane Market by Product Type, Source, Preservation Type, Formulation, Application - Global Forecast 2026-2032- Product Image
Amniotic Membrane Market by Product Type, Source, Preservation Type, Formulation, Application - Global Forecast 2026-2032- Product Image
Sale

Amniotic Membrane Market by Product Type, Source, Preservation Type, Formulation, Application - Global Forecast 2026-2032

  • Report

  • 181 Pages
  • June 2026
  • Region: Global
  • 360iResearch™
  • ID: 4995104
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Amniotic Membrane Market is projected to reach USD 4.29 Billion in 2026. It is expected to continue growing at a CAGR of 9.28%, reaching USD 7.34 Billion by 2032.

Amniotic membrane is a biologically active placental tissue used across ophthalmology, advanced wound care, burns, reconstructive surgery, and other regenerative medicine applications. Its extracellular matrix, collagen-rich structure, anti-inflammatory characteristics, and growth-factor profile support epithelialization and tissue repair when processed as cryopreserved, dehydrated, or lyophilized allografts.

Demand is supported by measurable clinical need. The International Diabetes Federation reported 537 million adults living with diabetes in 2021, a major driver of chronic wound prevalence, while the World Health Organization estimates that at least 2.2 billion people live with vision impairment. These disease burdens keep amniotic membrane products strategically important in diabetic foot ulcers, ocular surface reconstruction, burns, and soft-tissue repair pathways.

Transformative Shifts in the Amniotic Membrane Landscape

The amniotic membrane landscape is shifting from procedure-specific adoption to evidence-led use in high-burden care pathways such as diabetic foot ulcers, venous leg ulcers, corneal epithelial defects, pterygium surgery, burns, and surgical soft-tissue repair. Providers increasingly evaluate products based on clinical outcomes, tissue preservation method, shelf life, handling characteristics, reimbursement alignment, and compliance with tissue banking standards.

Commercial differentiation is also changing. Manufacturers are investing in standardized donor screening, validated sterilization or aseptic processing, traceability, cold-chain or room-temperature logistics, and physician education. As payers scrutinize wound care biologics, adoption is moving toward products supported by real-world evidence, randomized studies, clear labeling, and demonstrable health-economic value.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is beginning to compound value across the amniotic membrane ecosystem. In wound care, AI-enabled imaging can support wound measurement, tissue classification, infection-risk alerts, and longitudinal healing assessment, helping clinicians identify patients who may benefit from biologic dressings earlier in the care pathway.

AI also supports tissue operations by improving donor record review, batch documentation, quality surveillance, demand planning, inventory control, and adverse-event signal detection. The U.S. Food and Drug Administration has listed hundreds of AI- and machine-learning-enabled medical devices, demonstrating a broader regulatory pathway for digital tools that can complement regenerative medicine decision-making without replacing clinical judgment.

Key Regional Insights

North America remains a leading adoption region for amniotic membrane due to advanced wound care infrastructure, ophthalmic surgery volumes, established tissue banks, specialist training, and U.S. regulation of human cells, tissues, and cellular and tissue-based products under 21 CFR Part 1271. Canada adds a regulated tissue-safety environment and hospital-based procurement discipline, supporting controlled adoption in ocular and wound applications.

Europe benefits from strong hospital systems, tissue and cells oversight, advanced ophthalmology services, and growing use of amniotic membrane in ocular surface disease, corneal repair, burns, and chronic wound protocols. European adoption is shaped by evidence requirements, post-market surveillance expectations, and procurement processes that favor clinically documented products aligned with tissue governance and medical technology regulation.

Asia-Pacific is expanding as China, India, Japan, South Korea, Australia, and ASEAN markets invest in specialty eye care, diabetes management, burn care, and regenerative medicine capacity. The region’s large diabetes burden, rising surgical volumes, and expanding private hospital networks support broader awareness of amniotic tissue allografts, while country-specific regulatory pathways and reimbursement access continue to influence commercialization speed.

Latin America, the Middle East, and Africa present rising opportunity as diabetes, trauma, burns, and corneal disease create unmet need for advanced wound care and ophthalmic reconstruction. In Latin America, Brazil and Mexico are important care-access centers, while the Middle East is supported by specialty hospital investment and the GCC’s focus on high-value care. Across Africa, adoption remains uneven due to reimbursement gaps, procurement variability, tissue availability, and specialist access, but the clinical need remains substantial.

Key Group Insights

The G7 anchors premium demand for amniotic membrane through specialist hospitals, mature reimbursement frameworks, advanced ophthalmology, wound care networks, and established tissue-safety infrastructure. NATO markets similarly benefit from trauma care readiness, surgical capacity, and standardized medical logistics, supporting use in burns, reconstructive procedures, and complex wounds where biologic coverage and tissue repair support are clinically relevant.

The European Union is shaped by harmonized tissue governance, national competent authority oversight, and medical technology requirements that raise expectations for clinical evidence, quality systems, traceability, and post-market surveillance. These factors encourage adoption of amniotic tissue allografts that are supported by robust documentation, validated processing, and clear clinical-use protocols across hospital systems.

BRICS markets are increasingly important because China, India, Brazil, Russia, and South Africa combine large patient pools with expanding healthcare investment, high diabetes-related wound burden, and growing interest in regenerative medicine. ASEAN offers momentum through medical tourism, private hospital networks, specialty eye care, and diabetes care expansion, while the GCC emphasizes high-value specialty care, burn management, and imported advanced biologics supported by continued healthcare modernization.

Key Country Insights

The United States leads commercialization through advanced wound clinics, ophthalmic centers, tissue banking infrastructure, and a large diabetes burden; the CDC estimates 38.4 million Americans have diabetes. Canada emphasizes regulated tissue safety, hospital procurement, and specialist-led adoption, while Mexico and Brazil show opportunity in diabetic wound care, trauma, burns, and private-sector use of advanced biologic dressings.

In Europe, the United Kingdom, Germany, France, Italy, and Spain combine ophthalmology excellence with chronic wound demand, aging populations, and established hospital systems that support the clinical use of amniotic membrane in ocular surface repair and wound management. Russia remains influenced by local procurement structures, hospital modernization, and access to specialized biologic tissue products.

China and India offer substantial scale through large diabetes populations, expanding surgical volumes, and investment in tertiary care and regenerative medicine. Japan, South Korea, and Australia add high-quality clinical infrastructure, aging demographics, specialist ophthalmology services, and structured healthcare systems that support controlled adoption of amniotic membrane products for wound care, corneal defects, burns, and surgical repair.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically validated indications, transparent tissue sourcing, rigorous donor screening, and differentiated processing formats that match real practice needs. Building evidence in diabetic foot ulcers, venous leg ulcers, corneal epithelial defects, pterygium surgery, burns, and surgical soft-tissue repair can strengthen payer confidence and physician adoption.

Invest in AI-enabled wound documentation, outcomes registries, inventory traceability, and quality-system digitization. Regional go-to-market strategies should align product claims, reimbursement coding, clinician training, tissue handling requirements, and post-market surveillance with local regulation to reduce launch friction and protect long-term brand credibility.

Research Methodology

This executive summary is based on secondary research from public health agencies, regulatory frameworks, peer-reviewed clinical literature, tissue banking standards, and healthcare market intelligence. Sources include disease-burden indicators from the International Diabetes Federation, World Health Organization, CDC, and country-level healthcare authorities, alongside regulatory references such as U.S. HCT/P requirements and European tissue governance.

The analysis triangulates epidemiology, clinical adoption patterns, reimbursement considerations, product formats, regulatory expectations, tissue-processing practices, and regional healthcare capacity. Insights are interpreted through focused lens for amniotic membrane, amniotic tissue allografts, advanced wound care, ophthalmology, diabetic foot ulcers, ocular surface reconstruction, burns, and regenerative medicine applications.

Conclusion

The amniotic membrane market is positioned for sustained clinical relevance as healthcare systems confront rising diabetes, chronic wounds, ocular surface disorders, burns, trauma, and surgical repair needs. Products with reliable preservation, documented safety, traceable sourcing, compliant processing, and clinically meaningful outcomes will remain best positioned for adoption.

Future advantage will depend on evidence generation, regulatory discipline, payer alignment, physician education, and digital integration. Organizations that combine biologic quality with AI-supported care pathways and region-specific commercialization strategies can strengthen adoption while supporting measurable patient outcomes.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Amniotic Membrane Market, by Product Type
7.1. Amniotic Membrane Grafts
7.2. Amniotic Membrane-Derived Products
7.3. Amniotic Suspension Allografts
8. Amniotic Membrane Market, by Source
8.1. Bovine
8.2. Equine
8.3. Human
9. Amniotic Membrane Market, by Preservation Type
9.1. Cryopreserved Amniotic Membrane
9.2. Freeze-Dried Amniotic Membrane
9.3. Fresh Amniotic Membrane
9.4. Decellularized Amniotic Membrane
10. Amniotic Membrane Market, by Formulation
10.1. Sheet
10.2. Injectable Form
10.3. Particulate Form
11. Amniotic Membrane Market, by Application
11.1. Wound Care & Burns
11.2. Ophthalmology
11.3. Orthopedics & Sports Medicine
11.4. Dental & Oral Surgery
11.5. Plastic & Reconstructive Surgery
11.6. Gynecology & Urology
11.7. Regenerative Medicine
12. Asia-Pacific Amniotic Membrane Market
13. North America Amniotic Membrane Market
14. Latin America Amniotic Membrane Market
15. Europe Amniotic Membrane Market
16. Middle East Amniotic Membrane Market
17. Africa Amniotic Membrane Market
18. ASEAN Amniotic Membrane Market
19. GCC Amniotic Membrane Market
20. European Union Amniotic Membrane Market
21. BRICS Amniotic Membrane Market
22. G7 Amniotic Membrane Market
23. NATO Amniotic Membrane Market
24. United States Amniotic Membrane Market
25. Canada Amniotic Membrane Market
26. Mexico Amniotic Membrane Market
27. Brazil Amniotic Membrane Market
28. United Kingdom Amniotic Membrane Market
29. Germany Amniotic Membrane Market
30. France Amniotic Membrane Market
31. Russia Amniotic Membrane Market
32. Italy Amniotic Membrane Market
33. Spain Amniotic Membrane Market
34. China Amniotic Membrane Market
35. India Amniotic Membrane Market
36. Japan Amniotic Membrane Market
37. Australia Amniotic Membrane Market
38. South Korea Amniotic Membrane Market
39. Competitive Landscape
39.1. Market Concentration Analysis, 2025
39.1.1. Concentration Ratio (CR)
39.1.2. Herfindahl Hirschman Index (HHI)
39.2. Recent Developments & Impact Analysis, 2025
39.3. Product Portfolio Analysis, 2025
39.4. Benchmarking Analysis, 2025
40. Company Profiles
40.1. Alliqua BioMedical, Inc.
40.2. AlloSource
40.3. Amnio Technology, LLC
40.4. Applied Biologics, LLC
40.5. BioTissue Holdings, Inc.
40.6. Celularity Inc.
40.7. Corza Medical Inc.
40.8. Elutia Inc.
40.9. Human Regenerative Technologies, LLC
40.10. Integra LifeSciences Holdings Corporation
40.11. Katena Products, Inc.
40.12. LifeCell International Private Limited
40.13. Merakris Therapeutics, Inc.
40.14. MiMedx Group, Inc.
40.15. Next Biosciences Pty Ltd
40.16. NuVision Biotherapies Limited
40.17. Organogenesis Holdings Inc.
40.18. Skye Biologics Holdings, LLC
40.19. Surgenex, LLC
40.20. VIVEX Biologics, Inc.
List of Figures
FIGURE 1. GLOBAL AMNIOTIC MEMBRANE MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL AMNIOTIC MEMBRANE MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL AMNIOTIC MEMBRANE MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL AMNIOTIC MEMBRANE MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL AMNIOTIC MEMBRANE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 6. GLOBAL AMNIOTIC MEMBRANE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 7. GLOBAL AMNIOTIC MEMBRANE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL AMNIOTIC MEMBRANE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 9. GLOBAL AMNIOTIC MEMBRANE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL AMNIOTIC MEMBRANE MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL AMNIOTIC MEMBRANE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL AMNIOTIC MEMBRANE MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 13. GLOBAL AMNIOTIC MEMBRANE MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
FIGURE 14. GLOBAL AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 15. GLOBAL AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL AMNIOTIC MEMBRANE MARKET SIZE, BY SOURCE, 2025 VS 2032 (%)
FIGURE 17. GLOBAL AMNIOTIC MEMBRANE MARKET SIZE, BY SOURCE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL AMNIOTIC MEMBRANE MARKET SIZE, BY PRESERVATION TYPE, 2025 VS 2032 (%)
FIGURE 19. GLOBAL AMNIOTIC MEMBRANE MARKET SIZE, BY PRESERVATION TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL AMNIOTIC MEMBRANE MARKET SIZE, BY FORMULATION, 2025 VS 2032 (%)
FIGURE 21. GLOBAL AMNIOTIC MEMBRANE MARKET SIZE, BY FORMULATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 23. GLOBAL AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 25. ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. NORTH AMERICA AMNIOTIC MEMBRANE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 27. NORTH AMERICA AMNIOTIC MEMBRANE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 28. LATIN AMERICA AMNIOTIC MEMBRANE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 29. LATIN AMERICA AMNIOTIC MEMBRANE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 30. EUROPE AMNIOTIC MEMBRANE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 31. EUROPE AMNIOTIC MEMBRANE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 32. MIDDLE EAST AMNIOTIC MEMBRANE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 33. MIDDLE EAST AMNIOTIC MEMBRANE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 34. AFRICA AMNIOTIC MEMBRANE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 35. AFRICA AMNIOTIC MEMBRANE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 36. ASEAN AMNIOTIC MEMBRANE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 37. ASEAN AMNIOTIC MEMBRANE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 38. GCC AMNIOTIC MEMBRANE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 39. GCC AMNIOTIC MEMBRANE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 40. EUROPEAN UNION AMNIOTIC MEMBRANE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 41. EUROPEAN UNION AMNIOTIC MEMBRANE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 42. BRICS AMNIOTIC MEMBRANE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 43. BRICS AMNIOTIC MEMBRANE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 44. G7 AMNIOTIC MEMBRANE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 45. G7 AMNIOTIC MEMBRANE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 46. NATO AMNIOTIC MEMBRANE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 47. NATO AMNIOTIC MEMBRANE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 48. UNITED STATES AMNIOTIC MEMBRANE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 49. CANADA AMNIOTIC MEMBRANE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 50. MEXICO AMNIOTIC MEMBRANE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 51. BRAZIL AMNIOTIC MEMBRANE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 52. UNITED KINGDOM AMNIOTIC MEMBRANE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 53. GERMANY AMNIOTIC MEMBRANE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 54. FRANCE AMNIOTIC MEMBRANE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 55. RUSSIA AMNIOTIC MEMBRANE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 56. ITALY AMNIOTIC MEMBRANE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 57. SPAIN AMNIOTIC MEMBRANE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 58. CHINA AMNIOTIC MEMBRANE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 59. INDIA AMNIOTIC MEMBRANE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 60. JAPAN AMNIOTIC MEMBRANE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 61. AUSTRALIA AMNIOTIC MEMBRANE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 62. SOUTH KOREA AMNIOTIC MEMBRANE MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL AMNIOTIC MEMBRANE MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL AMNIOTIC MEMBRANE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL AMNIOTIC MEMBRANE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL AMNIOTIC MEMBRANE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL AMNIOTIC MEMBRANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL AMNIOTIC MEMBRANE MARKET SHARE, BY KEY PLAYER, 2025
TABLE 7. GLOBAL AMNIOTIC MEMBRANE MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
TABLE 8. GLOBAL AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL AMNIOTIC MEMBRANE GRAFTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL AMNIOTIC MEMBRANE GRAFTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL AMNIOTIC MEMBRANE GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL AMNIOTIC MEMBRANE-DERIVED PRODUCTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL AMNIOTIC MEMBRANE-DERIVED PRODUCTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL AMNIOTIC MEMBRANE-DERIVED PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL AMNIOTIC SUSPENSION ALLOGRAFTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL AMNIOTIC SUSPENSION ALLOGRAFTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL AMNIOTIC SUSPENSION ALLOGRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL AMNIOTIC MEMBRANE MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL BOVINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL BOVINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL BOVINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL EQUINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL EQUINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL EQUINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL HUMAN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL HUMAN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL HUMAN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL AMNIOTIC MEMBRANE MARKET SIZE, BY PRESERVATION TYPE, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL CRYOPRESERVED AMNIOTIC MEMBRANE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL CRYOPRESERVED AMNIOTIC MEMBRANE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL CRYOPRESERVED AMNIOTIC MEMBRANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL FREEZE-DRIED AMNIOTIC MEMBRANE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL FREEZE-DRIED AMNIOTIC MEMBRANE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL FREEZE-DRIED AMNIOTIC MEMBRANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL FRESH AMNIOTIC MEMBRANE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL FRESH AMNIOTIC MEMBRANE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL FRESH AMNIOTIC MEMBRANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL DECELLULARIZED AMNIOTIC MEMBRANE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL DECELLULARIZED AMNIOTIC MEMBRANE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL DECELLULARIZED AMNIOTIC MEMBRANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL AMNIOTIC MEMBRANE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL SHEET MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL SHEET MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL SHEET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL INJECTABLE FORM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL INJECTABLE FORM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL INJECTABLE FORM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL PARTICULATE FORM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL PARTICULATE FORM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL PARTICULATE FORM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL WOUND CARE & BURNS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL WOUND CARE & BURNS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL WOUND CARE & BURNS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL ORTHOPEDICS & SPORTS MEDICINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL ORTHOPEDICS & SPORTS MEDICINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL ORTHOPEDICS & SPORTS MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL DENTAL & ORAL SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL DENTAL & ORAL SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL DENTAL & ORAL SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL PLASTIC & RECONSTRUCTIVE SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL PLASTIC & RECONSTRUCTIVE SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL PLASTIC & RECONSTRUCTIVE SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL GYNECOLOGY & UROLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL GYNECOLOGY & UROLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL GYNECOLOGY & UROLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 75. ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 76. ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET SIZE, BY PRESERVATION TYPE, 2018-2032 (USD MILLION)
TABLE 77. ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 78. ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 79. NORTH AMERICA AMNIOTIC MEMBRANE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. NORTH AMERICA AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 81. NORTH AMERICA AMNIOTIC MEMBRANE MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 82. NORTH AMERICA AMNIOTIC MEMBRANE MARKET SIZE, BY PRESERVATION TYPE, 2018-2032 (USD MILLION)
TABLE 83. NORTH AMERICA AMNIOTIC MEMBRANE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 84. NORTH AMERICA AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 85. LATIN AMERICA AMNIOTIC MEMBRANE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. LATIN AMERICA AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 87. LATIN AMERICA AMNIOTIC MEMBRANE MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 88. LATIN AMERICA AMNIOTIC MEMBRANE MARKET SIZE, BY PRESERVATION TYPE, 2018-2032 (USD MILLION)
TABLE 89. LATIN AMERICA AMNIOTIC MEMBRANE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 90. LATIN AMERICA AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 91. EUROPE AMNIOTIC MEMBRANE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. EUROPE AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 93. EUROPE AMNIOTIC MEMBRANE MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 94. EUROPE AMNIOTIC MEMBRANE MARKET SIZE, BY PRESERVATION TYPE, 2018-2032 (USD MILLION)
TABLE 95. EUROPE AMNIOTIC MEMBRANE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 96. EUROPE AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 97. MIDDLE EAST AMNIOTIC MEMBRANE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. MIDDLE EAST AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 99. MIDDLE EAST AMNIOTIC MEMBRANE MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 100. MIDDLE EAST AMNIOTIC MEMBRANE MARKET SIZE, BY PRESERVATION TYPE, 2018-2032 (USD MILLION)
TABLE 101. MIDDLE EAST AMNIOTIC MEMBRANE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 102. MIDDLE EAST AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 103. AFRICA AMNIOTIC MEMBRANE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 104. AFRICA AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 105. AFRICA AMNIOTIC MEMBRANE MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 106. AFRICA AMNIOTIC MEMBRANE MARKET SIZE, BY PRESERVATION TYPE, 2018-2032 (USD MILLION)
TABLE 107. AFRICA AMNIOTIC MEMBRANE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 108. AFRICA AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 109. ASEAN AMNIOTIC MEMBRANE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 110. ASEAN AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 111. ASEAN AMNIOTIC MEMBRANE MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 112. ASEAN AMNIOTIC MEMBRANE MARKET SIZE, BY PRESERVATION TYPE, 2018-2032 (USD MILLION)
TABLE 113. ASEAN AMNIOTIC MEMBRANE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 114. ASEAN AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 115. GCC AMNIOTIC MEMBRANE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 116. GCC AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 117. GCC AMNIOTIC MEMBRANE MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 118. GCC AMNIOTIC MEMBRANE MARKET SIZE, BY PRESERVATION TYPE, 2018-2032 (USD MILLION)
TABLE 119. GCC AMNIOTIC MEMBRANE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 120. GCC AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 121. EUROPEAN UNION AMNIOTIC MEMBRANE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 122. EUROPEAN UNION AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 123. EUROPEAN UNION AMNIOTIC MEMBRANE MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 124. EUROPEAN UNION AMNIOTIC MEMBRANE MARKET SIZE, BY PRESERVATION TYPE, 2018-2032 (USD MILLION)
TABLE 125. EUROPEAN UNION AMNIOTIC MEMBRANE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 126. EUROPEAN UNION AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 127. BRICS AMNIOTIC MEMBRANE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 128. BRICS AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 129. BRICS AMNIOTIC MEMBRANE MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 130. BRICS AMNIOTIC MEMBRANE MARKET SIZE, BY PRESERVATION TYPE, 2018-2032 (USD MILLION)
TABLE 131. BRICS AMNIOTIC MEMBRANE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 132. BRICS AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 133. G7 AMNIOTIC MEMBRANE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 134. G7 AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 135. G7 AMNIOTIC MEMBRANE MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 136. G7 AMNIOTIC MEMBRANE MARKET SIZE, BY PRESERVATION TYPE, 2018-2032 (USD MILLION)
TABLE 137. G7 AMNIOTIC MEMBRANE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 138. G7 AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 139. NATO AMNIOTIC MEMBRANE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 140. NATO AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 141. NATO AMNIOTIC MEMBRANE MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 142. NATO AMNIOTIC MEMBRANE MARKET SIZE, BY PRESERVATION TYPE, 2018-2032 (USD MILLION)
TABLE 143. NATO AMNIOTIC MEMBRANE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 144. NATO AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 145. UNITED STATES AMNIOTIC MEMBRANE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 146. UNITED STATES AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 147. UNITED STATES AMNIOTIC MEMBRANE MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 148. UNITED STATES AMNIOTIC MEMBRANE MARKET SIZE, BY PRESERVATION TYPE, 2018-2032 (USD MILLION)
TABLE 149. UNITED STATES AMNIOTIC MEMBRANE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 150. UNITED STATES AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 151. CANADA AMNIOTIC MEMBRANE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 152. CANADA AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 153. CANADA AMNIOTIC MEMBRANE MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 154. CANADA AMNIOTIC MEMBRANE MARKET SIZE, BY PRESERVATION TYPE, 2018-2032 (USD MILLION)
TABLE 155. CANADA AMNIOTIC MEMBRANE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 156. CANADA AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 157. MEXICO AMNIOTIC MEMBRANE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 158. MEXICO AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 159. MEXICO AMNIOTIC MEMBRANE MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 160. MEXICO AMNIOTIC MEMBRANE MARKET SIZE, BY PRESERVATION TYPE, 2018-2032 (USD MILLION)
TABLE 161. MEXICO AMNIOTIC MEMBRANE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 162. MEXICO AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 163. BRAZIL AMNIOTIC MEMBRANE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 164. BRAZIL AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 165. BRAZIL AMNIOTIC MEMBRANE MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 166. BRAZIL AMNIOTIC MEMBRANE MARKET SIZE, BY PRESERVATION TYPE, 2018-2032 (USD MILLION)
TABLE 167. BRAZIL AMNIOTIC MEMBRANE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 168. BRAZIL AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 169. UNITED KINGDOM AMNIOTIC MEMBRANE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 170. UNITED KINGDOM AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 171. UNITED KINGDOM AMNIOTIC MEMBRANE MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 172. UNITED KINGDOM AMNIOTIC MEMBRANE MARKET SIZE, BY PRESERVATION TYPE, 2018-2032 (USD MILLION)
TABLE 173. UNITED KINGDOM AMNIOTIC MEMBRANE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 174. UNITED KINGDOM AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 175. GERMANY AMNIOTIC MEMBRANE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 176. GERMANY AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 177. GERMANY AMNIOTIC MEMBRANE MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 178. GERMANY AMNIOTIC MEMBRANE MARKET SIZE, BY PRESERVATION TYPE, 2018-2032 (USD MILLION)
TABLE 179. GERMANY AMNIOTIC MEMBRANE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 180. GERMANY AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 181. FRANCE AMNIOTIC MEMBRANE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 182. FRANCE AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 183. FRANCE AMNIOTIC MEMBRANE MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 184. FRANCE AMNIOTIC MEMBRANE MARKET SIZE, BY PRESERVATION TYPE, 2018-2032 (USD MILLION)
TABLE 185. FRANCE AMNIOTIC MEMBRANE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 186. FRANCE AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 187. RUSSIA AMNIOTIC MEMBRANE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 188. RUSSIA AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 189. RUSSIA AMNIOTIC MEMBRANE MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 190. RUSSIA AMNIOTIC MEMBRANE MARKET SIZE, BY PRESERVATION TYPE, 2018-2032 (USD MILLION)
TABLE 191. RUSSIA AMNIOTIC MEMBRANE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 192. RUSSIA AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 193. ITALY AMNIOTIC MEMBRANE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 194. ITALY AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 195. ITALY AMNIOTIC MEMBRANE MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 196. ITALY AMNIOTIC MEMBRANE MARKET SIZE, BY PRESERVATION TYPE, 2018-2032 (USD MILLION)
TABLE 197. ITALY AMNIOTIC MEMBRANE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 198. ITALY AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 199. SPAIN AMNIOTIC MEMBRANE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 200. SPAIN AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 201. SPAIN AMNIOTIC MEMBRANE MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 202. SPAIN AMNIOTIC MEMBRANE MARKET SIZE, BY PRESERVATION TYPE, 2018-2032 (USD MILLION)
TABLE 203. SPAIN AMNIOTIC MEMBRANE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 204. SPAIN AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 205. CHINA AMNIOTIC MEMBRANE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 206. CHINA AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 207. CHINA AMNIOTIC MEMBRANE MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 208. CHINA AMNIOTIC MEMBRANE MARKET SIZE, BY PRESERVATION TYPE, 2018-2032 (USD MILLION)
TABLE 209. CHINA AMNIOTIC MEMBRANE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 210. CHINA AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 211. INDIA AMNIOTIC MEMBRANE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 212. INDIA AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 213. INDIA AMNIOTIC MEMBRANE MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 214. INDIA AMNIOTIC MEMBRANE MARKET SIZE, BY PRESERVATION TYPE, 2018-2032 (USD MILLION)
TABLE 215. INDIA AMNIOTIC MEMBRANE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 216. INDIA AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 217. JAPAN AMNIOTIC MEMBRANE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 218. JAPAN AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 219. JAPAN AMNIOTIC MEMBRANE MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 220. JAPAN AMNIOTIC MEMBRANE MARKET SIZE, BY PRESERVATION TYPE, 2018-2032 (USD MILLION)
TABLE 221. JAPAN AMNIOTIC MEMBRANE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 222. JAPAN AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 223. AUSTRALIA AMNIOTIC MEMBRANE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 224. AUSTRALIA AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 225. AUSTRALIA AMNIOTIC MEMBRANE MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 226. AUSTRALIA AMNIOTIC MEMBRANE MARKET SIZE, BY PRESERVATION TYPE, 2018-2032 (USD MILLION)
TABLE 227. AUSTRALIA AMNIOTIC MEMBRANE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 228. AUSTRALIA AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 229. SOUTH KOREA AMNIOTIC MEMBRANE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 230. SOUTH KOREA AMNIOTIC MEMBRANE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 231. SOUTH KOREA AMNIOTIC MEMBRANE MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 232. SOUTH KOREA AMNIOTIC MEMBRANE MARKET SIZE, BY PRESERVATION TYPE, 2018-2032 (USD MILLION)
TABLE 233. SOUTH KOREA AMNIOTIC MEMBRANE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 234. SOUTH KOREA AMNIOTIC MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)

Companies Mentioned

The companies featured in this Amniotic Membrane market report include:
  • Alliqua BioMedical, Inc.
  • AlloSource
  • Amnio Technology, LLC
  • Applied Biologics, LLC
  • BioTissue Holdings, Inc.
  • Celularity Inc.
  • Corza Medical Inc.
  • Elutia Inc.
  • Human Regenerative Technologies, LLC
  • Integra LifeSciences Holdings Corporation
  • Katena Products, Inc.
  • LifeCell International Private Limited
  • Merakris Therapeutics, Inc.
  • MiMedx Group, Inc.
  • Next Biosciences Pty Ltd
  • NuVision Biotherapies Limited
  • Organogenesis Holdings Inc.
  • Skye Biologics Holdings, LLC
  • Surgenex, LLC
  • VIVEX Biologics, Inc.

Table Information

Report AttributeDetails
No. of Pages181
PublishedJune 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 4.29 Billion
Forecasted Market Value ( USD ) by 2032 $ 7.34 Billion
Compound Annual Growth Rate9.2%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Topics

Related Reports

Amniotic Membrane - Global Strategic Business Report - Product Image

Amniotic Membrane - Global Strategic Business Report

  • Report
  • 375 Pages
  • Global
From
Amniotic Membrane Graft Market - Global Forecast 2025-2030 - Product Image

Amniotic Membrane Graft Market - Global Forecast 2025-2030

  • Report
  • 190 Pages
  • Global
From
Amniotic Membrane for Ophthalmology Market - Global Forecast 2025-2030 - Product Image

Amniotic Membrane for Ophthalmology Market - Global Forecast 2025-2030

  • Report
  • 185 Pages
  • Global
From
Amniotic Membrane Market Size, Share, Trends and Forecast by Product, Application, End User, and Region, 2026-2034 - Product Image

Amniotic Membrane Market Size, Share, Trends and Forecast by Product, Application, End User, and Region, 2026-2034

  • Report
  • 138 Pages
  • Global
From
Amniotic Membrane Market Report 2026 - Product Image

Amniotic Membrane Market Report 2026

  • Report
  • 250 Pages
  • Global
From

About the Amniotic Membrane Market

The Amniotic Membrane market within the context of Wound Care is a rapidly growing sector. Amniotic Membrane is a natural, biologic material derived from the amniotic sac of a healthy donor. It is used in wound care to promote healing and reduce inflammation. It is a versatile material that can be used in a variety of wound care applications, including burns, ulcers, and surgical wounds. It is also used to reduce pain and discomfort associated with wound care. Amniotic Membrane is a cost-effective and safe alternative to traditional wound care treatments. It is easy to apply and can be used in a variety of settings, including hospitals, clinics, and home care. It is also a sustainable product, as it is derived from a renewable source. The Amniotic Membrane market is highly competitive, with many companies offering products and services. Some of the major players in the market include MiMedx, Amnio Technology, AmnioLife, and AmnioMatrix. Other companies in the market include AmnioTech, AmnioCare, and AmnioLife Technologies. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.